AA
PBH icon

AlphaMark Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

AlphaMark Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,876
Closed -$352K – 704
2024
Q3 		$352K Buy
+4,876
New +$345K 0.12% 129

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

AlphaMark Advisors's PBH Position: Q4 2024 in Review

AlphaMark Advisors sold out of Prestige Consumer Healthcare (PBH) in Q4 2024, closing a stake of 4,876 shares — an estimated $352K sold.

AlphaMark Advisors first reported a position in PBH in Q3 2024 and held it in 1 quarter. The position peaked at $352K in Q3 2024. 336 funds tracked by Wall St. Rank hold PBH as of Q4 2024.

  • AlphaMark Advisors reported no remaining Prestige Consumer Healthcare position as of Q4 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 4,876 Prestige Consumer Healthcare shares in Q4 2024, an estimated $352K.
  • AlphaMark Advisors first reported a position in Prestige Consumer Healthcare in Q3 2024 and held it in 1 quarter.
  • AlphaMark Advisors's Prestige Consumer Healthcare position peaked at $352K in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.